Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px

News > All

Total search results: 9941 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 98 99 100  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Santhera Pharmaceuticals Holding AG. (2/10/17). "Press Release: Santhera Launches Senior Convertible Bond Issue [Not for US, CA, AU or JP]". Liestal. 2017-02-10
Santhera Pharmaceuticals Holding AG. (2/10/17). "Press Release: Santhera Successfully Places CHF 60 million Senior Convertible Bonds [Not for US, CA, AU or JP]". Liestal. 2017-02-10
Merck KGaA. (2/9/17). "Press Release: Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with Multiple Sclerosis". Darmstadt. 2017-02-09
Medivir AB. (2/9/17). "Press Release: Christine Lind New CEO of Medivir AB Effective 1 April 2017". Stockholm. 2017-02-09
Evotec AG. (2/9/17). "Press Release: Novo A/S Becomes New Long-term Strategic Shareholder in Evotec". Hamburg. 2017-02-09
Cevec Pharmaceuticals GmbH. (2/9/17). "Press Release: Cevec Licenses CAP Technologies for the Development and Commercialization of Vaccines against Zika Virus Infections". Cologne. 2017-02-09
Neovacs S.A.. (2/9/17). "Press Release: Neovacs Issued New Broad Patent in China for IFNalpha Kinoid". Paris. 2017-02-09
Nicox S.A.. (2/9/17). "Press Release: Nicox to Present at the 6th Annual Leerink Partners Global Healthcare Conference". Sophia Antipolis. 2017-02-09
Merus N.V.. (2/9/17). "Press Release: Merus to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Utrecht. 2017-02-09
Analytik Jena AG. (2/9/17). "Press Release: Analytik Jena Wins New Product Award for Innovation in Nucleic Acid Extraction at SLAS 2017". Jena & Washington, DC. 2017-02-09
Euronext N.V.. (2/8/17). "Press Release: Lysogene Lists on Euronext. €22.6 Million Raised, Market Capitalisation of approximately €82 Million". Paris. 2017-02-08
Pieris Pharmaceuticals, Inc.. (2/8/17). "Press Release: Pieris Pharmaceuticals to Present at the Bio CEO Investor Conference on February 13th at 1:30 pm EST". Boston, MA. 2017-02-08
Minoryx Therapeutics S.L.. (2/8/17). "Press Release: Dr Claude Nicaise Joins Minoryx Therapeutics as Independent Board Member". Mataró, Barcelona. 2017-02-08
Bayer AG. (2/8/17). "Press Release: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early []". Berlin. 2017-02-08
Affimed N.V.. (2/8/17). "Press Release: Affimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Heidelberg. 2017-02-08
Prothena Corporation plc. (2/8/17). "Press Release: Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference". Dublin. 2017-02-08
Albany Molecular Research, Inc.. (2/7/17). "Press Release: AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery". Albany, NY. 2017-02-07
MolMed S.p.A.. (2/7/17). "Press Release: MolMed and TTY Biopharm Entered into a Term Sheet to Commercialise Zalmoxis in certain Asian Territories". Milan. 2017-02-07
Global Bioenergies S.A.. (2/7/17). "Press Release: First Production in History of Fully Renewable ETBE". Évry. 2017-02-07
GeNeuro S.A.. (2/7/17). "Press Release: GeNeuro Signs CRADA Agreement with NIH to Develop Novel Antibody Treatment for ALS". 2017-02-07
Forbion Capital Partners. (2/7/17). "Press Release: Forbion Invests in Prexton Therapeutics’ EUR 29 Million (USD 31 Million) Series B Financing". Naarden. 2017-02-07
Pieris Pharmaceuticals, Inc.. (2/7/17). "Press Release: Pieris Announces Management Transition". Boston, MA. 2017-02-07
Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. 2017-02-07
OSE Immunotherapeutics S.A.. (2/7/17). "Press Release: OSE Immunotherapeutics to Present Corporate Overview at Upcoming BIO CEO & Investor Conference New York February 13-14, 2017". Nantes. 2017-02-07
Pharnext S.A.. (2/7/17). "Press Release: Pharnext to Present at 2017 BIO CEO & Investor Conference". Paris. 2017-02-07
Numares AG. (2/7/167). "Press Release: Numares Initiates Worldwide Commercial Launch of insightLPTM-S50 to Provide New Insights in Lipoprotein Research". Regensburg. 2017-02-07
Atriva Therapeutics GmbH. (2/7/17). "Press Release: Atriva Receives Seed Financing to Develop Its Next Generation Influenza Therapeutic". Tübingen. 2017-02-07
Atriva Therapeutics GmbH. (2/7/17). "Press Release: Atriva Reaches a Development Milestone and Receives an Additional Tranche of Running Seed Financing to Develop Its Influenza Therapeutic to Clinical Stage". Tübingen. 2017-02-07
Genedata AG. (2/6/17). "Press Release: SLAS2017 – Genedata Announces BMG LABTECH, Creoptix and TTP Labtech as New Ready-to-Run Partners". Washington, DC. 2017-02-06
Analytik Jena AG. (2/6/17). "Press Release: One Million Tests a Week – Analytik Jena Optimizes the Process for Ultra High Throughput Screening". Jena & Washington, DC. 2017-02-06
Lipotype GmbH. (2/6/17). "Press Release: Launch of BEAt-DKD. An Innovative Medicines Initiative (IMI) Project for Precision Medicine in Diabetic Kidney Disease with Lipotype as Project Partner". 2017-02-06
Wilex AG. (2/6/17). "Press Release: Wilex AG Secures Financing Commitment from Its Main Shareholder Dievini". Munich. 2017-02-06
Isogenica Ltd.. (2/6/17). "Press Release: Isogenica Announces New Licence Agreement with Maverick Therapeutics". Cambridge. 2017-02-06
4SC AG. (2/6/17). "Press Release: 4SC AG to Present at the 19th Annual BIO CEO & Investor Conference 2017". Planegg-Martinsried. 2017-02-06
Quotient Clinical. (2/6/17). "Press Release: Quotient Clinical Expands into USA through Acquisition of SeaView Research, the Specialist Clinical Pharmacology Business". Nottingham. 2017-02-06
Bruker Corporation. (2/6/17). "Press Release: Bruker Introduces MALDI PharmaPulse 2.0 Solution at SLAS 2017 for 100x Faster Mass Spectrometry-Based, Label-Free Screening in Drug Discovery". 2017-02-06
Uniqure N.V.. (2/6/17). "Press Release: Uniqure Announces Presentations at Upcoming February Conferences". Lexington, MA & Amsterdam. 2017-02-06
Ablynx N.V.. (2/6/17). "Press Release: Ablynx Submits a Marketing Authorisation Appolcation to the European Medicines Agency for Caplacizumab, Its anti-vWF Nanobody, for the Treatment of aTTP". Ghent. 2017-02-06
UV-Cap GmbH & Co. KG. (2/3/17). "Press Release: UV-Cap GmbH & Co KG Acquires Scil Proteins GmbH. Scil Proteins GmbH Becomes Navigo Proteins GmbH". Halle (Saale). 2017-02-03
Immunicum AB. (2/3/17). "Press Release: Immunicum AB CEO to present at BIO CEO & Investor Conference". Gothenburg. 2017-02-03
Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. 2017-02-03
IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. 2017-02-03
Protagen AG. (2/2/17). "Press Release: Protagen AG Join Forces with the U.S. National Cancer Institute to Answer Pressing Questions in Immuno-oncology". 2017-02-02
Euronext N.V.. (2/2/17). "Press Release: Euronext and Biotech Bourse Launch First Quarterly Barometer for Biotech Sector". Amsterdam, et al.. 2017-02-02
Medigene AG. (2/2/17). "Press Release: Medigene Participates at Five National and International Conferences in February and March 2017". Martinsried. 2017-02-02
Sygnis AG. (2/2/17). "Press Release: Sygnis AG Announces the Launch of TrueHelix". Madrid & Heidelberg. 2017-02-02
Rentschler Biotechnologie GmbH. (2/2/17). "Press Release: Rentschler and Leukocare Announce Strategic Alliance And Equity Investment". Laupheim & Martinsried. 2017-02-02
AstraZeneca plc. (2/2/17). "Press Release: Full-year and Q4 2016 Results". 2017-02-02
Otto Bock HealthCare GmbH. (2/2/17). "Press Release: Into the Future Hand in Hand. Ottobock Acquires BeBionic from Steeper". 2017-02-02
Reading Scientific Services Ltd.. (2/2/17). "Press Release: RSSL Microbiology Laboratory Expansion". 2017-02-02
Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. 2017-02-02
Johnson & Johnson. (2/2/17). "Press Release: Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions". Cambridge, MA. 2017-02-02
InSphero AG. (2/2/17). "Press Release: InSphero to Introduce GravityTRAP 384 Microtissue Platform at SLAS2017". Schlieren. 2017-02-02
Merck KGaA. (2/1/17). "Press Release: Merck Appoints Anke Schenkel as Head of Group Controlling and Risk Management". Darmstadt. 2017-02-01
Axxam S.p.A.. (2/1/17). "Press Release: Axxam and Fulcrum Therapeutics Initiate a Partnership for the Provision of Drug Discovery Services for Genetic Diseases". 2017-02-01
Galapagos N.V.. (2/1/17). "Press Release: Galapagos Doses First Patient with Novel CF Corrector GLPG2222. IND Opening Triggers $10 Million Milestone Payment from AbbVie". Mechelen. 2017-02-01
Qiagen N.V.. (2/1/17). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2016". Paris. 2017-02-01
Genedata AG. (2/1/17). "Press Release: New Genedata Screener APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017". Basel & Munich. 2017-02-01
Immunic AG. (2/1/17). "Press Release: Immunic Adds EUR 4 Million in Funding to Further Boost Development. Series A Financing Round Extended to EUR 21.7 Million". Planegg-Martinsried & Magdeburg. 2017-02-01
Lonza Group AG. (2/1/17). "Press Release: Lonza Successfully Places 5.0 Million New Shares, Raising Gross Proceeds of CHF 865 Million [Not for US, CA, JP or AU]". Basel. 2017-02-01
IP Group plc. (2/1/17). "Press Release: Completion of Acquisition of Parkwalk". 2017-02-01
Agilent Technologies Inc.. (1/31/17). "Press Release: Agilent Technologies Expands Dako’s CE Marked PD-L1 IHC 22C3 pharmDx Companion Diagnostics". Carpinteria, CA. 2017-01-31
Thermo Fisher Scientific Inc.. (1/31/17). "Press Release: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results". Waltham, MA. 2017-01-31
Stolmár & Partner Patentanwälte. (1/31/17). "Press Release: Stolmár & Partners Is Excited to Welcome Dr. Leopold Gruner in Our Life Science Team". 2017-01-31
Optibrium Ltd.. (1/31/17). "Press Release: Optibrium Signs Agreement with Zastra Innovations for Distribution in India". Cambridge & Bengaluru. 2017-01-31
Indivumed GmbH. (1/31/17). "Press Release: Indivumed Announces Agreement with Regeneron to Provide Tissue Samples for Oncology Research and Development". Hamburg. 2017-01-31
Xeltis AG. (1/31/17). "Press Release: FDA Gives Xeltis Go Ahead to Begin Trials in the USA". 2017-01-31
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. 2017-01-31
Heptares Therapeutics Ltd.. (1/31/17). "Press Release: Heptares Enters a New Research Collaboration under its "ORBIT" Initiative with the University of Cambridge". London & Cambridge. 2017-01-31
Evotec AG. (1/30/17). "Press Release: Evotec to Attend Three Upcoming Investor Conferences". Hamburg. 2017-01-30
AstraZeneca plc. (1/30/17). "Press Release: US FDA Approves Symbicort (budesonide/formoterol) for the Treatment of Asthma in Paediatric Patients". 2017-01-30
ElsaLys Biotech S.A.S.. (1/30/17). "Press Release: ElsaLys Biotech Expands Its Team to Strengthen Its Strategy and the Development of Its Programs". Lyon. 2017-01-30
Qiagen N.V.. (1/30/17). "Press Release: Qiagen Hereditary and Rare Disease Solution Chosen by Genomics England". Hilden & London. 2017-01-30
Technische Universität München. (1/30/17). "Press Release: ProteomeTools – Synthetic Peptides and Spectra for Proteomics. Milestone for the Analysis of Human Proteomes". 2017-01-30
Bruker Corporation. (1/30/17). "Press Release: Bruker and iTomography Corporation Announce License Agreement for iTomo Image Reconstruction Software". Kontich. 2017-01-30
Sartorius AG. (1/30/17). "Press Release: Sartorius Stedim Biotech – 2016 Targets Fully Achieved; Strong Outlook for 2017". 2017-01-30
Sartorius AG. (1/30/17). "Press Release: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017". Göttingen. 2017-01-30
Sanofi S.A.. (1/30/17). "Press Release: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs". Paris. 2017-01-30
Novo Nordisk A/S. (1/30/17). "Press Release: Novo Nordisk Enters Collaboration with University of Oxford on Type 2 Diabetes and Invests GBP 115m in New Research Centre". Bagsværd. 2017-01-30
Sonic Healthcare Ltd.. (1/30/17). "Press Release: Acquisition of Medical Laboratory Bremen. Completion of Staber Laboratory Group and GLP Systems Acquisitions". 2017-01-30
Varex Imaging Corporation. (1/30/17). "Press Release: Varex Imaging Completes Separation from Varian Medical Systems, Lists on the Nasdaq Stock Market". Salt Lake City, UT. 2017-01-30
Arcis Biotechnology Ltd.. (1/30/17). "Press Release: Arcis Biotechnology Awarded Funding under Innovate UK’s Biocatalyst Programme". Daresbury. 2017-01-30
Valo Therapeutics Ltd.. (1/30/17). "Press Release: Valo Therapeutics Closes Seed Fundraising Round to Develop a Novel Oncolytic Virus-based Cancer Immunotherapy". 2017-01-30
SGS S.A.. (1/30/17). "Press Release: SGS Issues CHF 375 Million Benchmark Bond [Not for any jurisdiction where unlawful and not for United States]". 2017-01-30
ViroVet N.V.. (1/27/17). "Press Release: Dr George Gunn, Former CEO of Novartis Animal Health, Appointed as Chairman at ViroVet". Leuven. 2017-01-27
Recordati Industria Chimica e Farmaceutica S.p.A.. (1/27/17). "Press Release: Recordati Announces Marketing Approval for Cystadrops". Milan. 2017-01-27
Stallergenes Greer plc. (1/27/17). "Press Release: Stallergenes Greer Announces Positive Top-line Results of Phase 3 Study for Pediatric House Dust Mite-induced Allergic Rhinitis". 2017-01-27
Qiagen N.V.. (1/26/17). "Press Release: Qiagen’s QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits". Hilden & Seoul. 2017-01-26
ADx NeuroSciences N.V.. (1/26/17). "Press Release: ADx NeuroSciences Receives 850.000 EUR Support from Flemish Government for Tracking Brain Disorders". 2017-01-26
Celgene Corporation. (1/26/17). "Press Release: Celgene to Acquire Delinia, Inc.". Summit, NJ & Cambridge, MA. 2017-01-26
Actelion Ltd.. (1/26/17). "Press Release: Johnson & Johnson to Acquire Actelion for $30 Billion with Spin-out of New R&D Company". New Brunswick, NJ & Allschwil. 2017-01-26
DiaSorin S.p.A.. (1/26/17). "Press Release: DiaSorin Launches the Liaison FGF 23 Test, the First Innovative and Fully Automted Marker for Chronic Kidney Disease". Saluggia. 2017-01-26
c-LEcta GmbH. (1/26/17). "Press Release: c-LEcta Starts Marketing & Distribution of Denarase". 2017-01-26
Cellectricon AB. (1/26/17). "Press Release: Cellectricon and Censo Biotechnologies Introduce a Joint Technology Access Program Utilizing High-quality Human iPSC-based Discovery Services for CNS and Pain Research". Mölndal & Cambridge. 2017-01-26
Iproteos S.L.. (1/26/17). "Press Release: Grant of 700,000 € for the Discovery of Drugs against Atherosclerosis". 2017-01-26
Cellestia Biotech AG. (1/26/17). "Press Release: Cellestia Biotech Raises CHF 8 Million Seed Financing from Private Investors and PPF Group to Advance Its Lead Anti-cancer Compound CB-103 to Clinical Development Stage". Basel. 2017-01-26
Oxford BioTherapeutics Ltd.. (1/26/17). "Press Release: Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics". Alexandria, VA, San José, CA & Oxford. 2017-01-26
Caelus Health. (1/26/17). "Press Release: Caelus Health Announces First Closing of a Series A Financing Round to Advance Microbiota-based Therapeutics for Cardio-metabolic Disorders". Amsterdam. 2017-01-26
ObsEva S.A.. (1/25/17). "Press Release: ObsEva SA Announces Pricing of Initial Public Offering". Geneva. 2017-01-25
BioIndustry Assocation (BIA). (1/25/17). "Press Release: Innovative UK Companies Tackle Antimicrobial Resistance, Dementia and Long Term Disease Thanks to Government £26 Million Start-up Funding Awards". 2017-01-25
next pagenext page 1 2 3 ... 98 99 100  next pagenext page


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px

» top